Life Science REIT PLC (LABS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Life Science REIT PLC (LABS) has a cash flow conversion efficiency ratio of 0.004x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX958.00K ≈ $116.56 USD) by net assets (GBX233.06 Million ≈ $28.36K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Life Science REIT PLC (LABS) total market value for the company's overall valuation and market capitalisation.
Life Science REIT PLC - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Life Science REIT PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Life Science REIT PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Life Science REIT PLC ranked by their cash flow conversion efficiency. Explore LABS cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Regional REIT Ltd
LSE:RGL
|
0.026x |
|
Fintech Chain Ltd
AU:FTC
|
-0.019x |
|
ETRUSCUS RESOURCES CORP.
F:ERR
|
-0.014x |
|
Qlucore AB
ST:QCORE
|
-0.194x |
|
Pantheon Resources
LSE:PANR
|
0.006x |
|
Drugs Made In America Acquisition Corp. Rights
NASDAQ:DMAAR
|
N/A |
|
Middlefield Canadian Income PCC - Middlefield Canadian Income - GBP PC
LSE:MCT
|
0.005x |
|
Shuttle Pharmaceuticals Inc
NASDAQ:SHPH
|
-0.722x |
Annual Cash Flow Conversion Efficiency for Life Science REIT PLC (2021–2024)
The table below shows the annual cash flow conversion efficiency of Life Science REIT PLC from 2021 to 2024. View current stock price of Life Science REIT PLC for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX262.77 Million ≈ $31.97K |
GBX12.92 Million ≈ $1.57K |
0.049x | +83.22% |
| 2023-12-31 | GBX283.75 Million ≈ $34.52K |
GBX7.62 Million ≈ $926.53 |
0.027x | +887.98% |
| 2022-12-31 | GBX319.45 Million ≈ $38.87K |
GBX-1.09 Million ≈ $-132.38 |
-0.003x | -133.75% |
| 2021-12-31 | GBX350.58 Million ≈ $42.66K |
GBX3.54 Million ≈ $430.47 |
0.010x | -- |
About Life Science REIT PLC
Life Science REIT plc is a specialist property business focused on the UK's growing life science sector. The Company's portfolio of assets is located across the Golden Triangle of research and development hubs in Oxford, Cambridge and London's Knowledge Quarter. Life Science REIT trades on the Main Market of the London Stock Exchange under the ticker LABS.